PCTC
CLB icon

Perkins Coie Trust Company’s Core Laboratories CLB Stock Holding History

Perkins Coie Trust Company’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-140
Closed -$2.84K – 288
2024
Q2 		$2.84K Buy
+140
New +$2.48K ﹤0.01% 250

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Perkins Coie Trust Company's CLB Position: Q3 2024 in Review

Perkins Coie Trust Company sold out of Core Laboratories (CLB) in Q3 2024, closing a stake of 140 shares — an estimated $2.84K sold.

Perkins Coie Trust Company first reported a position in CLB in Q2 2024 and held it in 1 quarter. The position peaked at $2.84K in Q2 2024. 191 funds tracked by Wall St. Rank hold CLB as of Q3 2024.

  • Perkins Coie Trust Company reported no remaining Core Laboratories position as of Q3 2024 after selling out during the quarter.
  • Perkins Coie Trust Company sold 140 Core Laboratories shares in Q3 2024, an estimated $2.84K.
  • Perkins Coie Trust Company first reported a position in Core Laboratories in Q2 2024 and held it in 1 quarter.
  • Perkins Coie Trust Company's Core Laboratories position peaked at $2.84K in Q2 2024.
  • 191 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2024.

Based on Perkins Coie Trust Company's 13F filing for Q3 2024, filed 8 Oct 2024.